Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-covid-19_-_covent_garden_london_uk_during_lockdown

UK Government ignored SAGE advice to impose full lockdown last month

October 13, 2020
Manufacturing and Production COVID, UK, UK Coronavirus, coronavirus

UK Government ministers ignored warnings three weeks ago that the country should go into a temporary full lockdown to reduce …

News
shutterstock_3

University of Glasgow research details promising precision medicine approach in pancreatic cancer

October 12, 2020
Research and Development, Sales and Marketing Cancer, Precision Medicine

Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients …

News
citizens_of_wuhan_lining_up_outside_of_a_drug_store_to_buy_masks_during_the_wuhan_coronavirus_outbreak

China to test entire population of Qingdao over nine days

October 12, 2020
Sales and Marketing coivd-19, coronavirus, pandemic, virus

China plans to test the entire city of Qingdao, containing nine million people, for coronavirus over a period of five …

News
800px-joe_biden_48554137807

Pharmaceutical industry donating more to Democrats than Republicans in the lead up to 2020 election

October 12, 2020
Sales and Marketing

The long-term trend of the pharmaceutical industry largely donating to the US Republican Party has been reversed in the lead …

News
800px-new_zealand_parliament_house_in_2016

New Zealand Government signs deal with Pfizer and BioNTech for 1.5 million COVID-19 vaccines

October 12, 2020
Sales and Marketing

The New Zealand Government has signed a deal with Pfizer and BioNTech for one of their promising COVID-19 vaccine candidates.  …

News
download_3

Sun Pharma issues recall of its generic diabetes drug in US market

October 12, 2020
Sales and Marketing FDA, diabetes, recall

Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.This is due to an …

News

Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

October 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments

BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …

Appointment
download_2

Dr Sarah Noonberg appointed Chief Medical Officer of Maze Therapeutics

October 9, 2020
Medical Communications

Maze Therapeutics has appointed Dr Sarah Noonberg as its Chief Financial Officer. Noonberg is a physician-scientist with expertise in global …

Appointment
shutterstock_273326141

Takeda and Arrowhead Pharma join forces in $1m rare liver disease drug development pact

October 9, 2020
Medical Communications, Research and Development Arrowhead, Takeda, pharma

A new partnership has been struck between Takeda and Arrowhead Pharmaceuticals, with both companies coming together to co-develop and license …

News
shutterstock

Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal

October 9, 2020
Medical Communications Amgen, cytokines, heart failure, pharma

New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …

News
800px-us_supreme_court

US Supreme Court refuses Trump administration’s request to restrict delivery of abortion medication

October 9, 2020
Medical Communications abortion, abortion pill

The US Supreme Court has struck down a request from the Trump administration to restrict delivery of abortion medicine during …

News
jnjioffice

European Commission agrees deal with Janssen for 200 million doses of its COVID-19 vaccine

October 9, 2020
Medical Communications AZ, AstraZeneca, Janssen

The European Commission has approved an agreement with Johnson & Johnson for the supply of 200 million doses of Janssen’s …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 9, 2020
Medical Communications coronavirus, news

The top ten news stories this week focus on clinical trial data, as Amgen and Novartis have revealed new five-year …

News
david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …

Appointment
nick_johnson_-_colour_2_1

Dr Nick Johnson appointed as Chief Strategy and Impact Officer of CGT Catapult

October 8, 2020
Business Services

Dr Nick Johnson has been appointed the Chief Strategy and Impact Officer of the Cell and Gene Therapy Catapult. Johnson …

Appointment
800px-eli_lilly_corporate_center_indianapolis_indiana_usa

Eli Lilly’s antibody COVID-19 therapy reduces virus levels and hospitalisations

October 8, 2020
Manufacturing and Production Eli Lilly, FDA

Eli Lilly is seeking Emergency Use Authorization from the FDA after releasing interim data based on early trial results.

News
800px-white_house_dc

34 reported coronavirus infections in White House-linked staff

October 8, 2020
Medical Communications COVID, Trump, US, white house

The coronavirus outbreak that has infected notable figures of the Trump administration has spread to 34 White House Staffers and …

News
nhs-westminster

COVID-19 has caused over three times more deaths than flu or pneumonia in England and Wales

October 8, 2020
Medical Communications, Research and Development COVID-19, UK, flu

Newly released data has revealed that COVID-19 has resulted in many more deaths than influenza or pneumonia in England and …

News
president_of_the_united_states_donald_j

Regeneron applies for FDA Emergency Use Authorization for COVID-19 antibody treatment given to Trump

October 8, 2020
Manufacturing and Production COVID, Trump, coronavirus

Regeneron has announced that it has applied for an Emergency Use Authorization from the FDA for its experimental antibody therapy …

News
shutterstock_2

Gilead to meet rising remdesivir demand in Europe with new supply deal

October 8, 2020
Manufacturing and Production COVID-19, Europe, Gilead

The European Commission (EC) has signed a new joint procurement agreement (JPA) with pharma firm Gilead to improve access to …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025